The slip
PARKINSON RECEIPTno. 7990
23 Oct 2026, 22:37 UTCdopamine neurons, braak
predictionZNF638 in dopamine neurons tracks Braak Lewy-body stage
registered73c22b9d32afec10
discovery+0.14 p=0.725 n=9
replication-0.06 p=0.874 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.14, p 0.725)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTca6b53902dde3c798a41577f…
follows 0f09387f26ab…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7990: ZNF638 in dopamine neurons, braak
- power
- full sample -0.01 (p 0.962, n 18), 95% CI -0.48 to +0.46. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.01 (p 0.962, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.07 (p 0.794, n 18). could be the mix.
- skeptic
- leave-one-out range -0.15 to +0.07, sign flips 12; without severely affected donors -0.01 (p 0.962, n 18). fragile.
- cell type
- strongest in microglia: -0.75 (p 3.1e-4, n 18) vs -0.01 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZNF638 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ZNF638 · microglia · braak: substantia nigra, an independent cohort (already registered)